Global Oncology nutrition Market
Global Oncology nutrition Market

Oncology nutrition Comprehensive Study by Demography (Infants, Adults, Children, Others), Cancer Type (Blood, Liver, Pancreatic, Breast, Lung, Head & Neck, Esophageal, Stomach & Gastrointestinal) Players and Region - Global Market Outlook to 2025

Oncology nutrition Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024 | CAGR: 8.2%  

Jan 2019 Edition 222 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Oncology nutrition Market Overview:
Nutrition therapy which is used to help cancer patients to maintain strength, keeps a healthy body weight, keeps body tissue healthy, as well as decreases side effects both during and after treatment is known as Oncology Nutrition. Cancer treatments and the Cancer might affect human sensations including smell, taste, appetite, as well as minimizes the ability to eat and digest enough food or absorb the nutrients from food. These affects can cause malnutrition, which is a condition caused by a lack of key nutrients. Nutrition is a process to take food inside the human body and used by the body for growth and to keep the body healthy. Some of the key players profiled in the study are Abbott Laboratories (United States), Aceto (United States), B. Braun Melsungen AG (Germany), Baxter International (United States), BioSig Technologies (United States), Danone (France), FMC Corporation (United States), Fresenius Kabi AG (Germany), Global Health Products (United States) and Hansen Medical (United States). According to Market Analyst at AMA, the Global Oncology nutrition market may see a growth rate of 8.2% and would reach the market size of USD3.1 Billion by 2024.

On the basis of geography, the market of Oncology nutrition has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Demography, the sub-segment i.e. Infants will boost the Oncology nutrition market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Cancer Type, the sub-segment i.e. Blood will boost the Oncology nutrition market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Prevalence of Cancer
  • Rising Demand for the Nutritional Food

Market Trend
  • Growing Instances of Extreme Weight Loss in Cancer Patients
  • Increasing Demand in Homecare Sector

Restraints
  • Continues Product Innovations
  • Side Effects of Few Oncology Nutrients may Hamper Business Growth

Opportunities
  • Up surging Nutritional Interventions and Rapid Product Innovations
  • Enhancements in Clinical Research and Nutritional Food Product Developments

Challenges
  • Complications Related to Tube Feeding
  • Lack of Government Assistance in Generating Reimbursements


Major Market Developments:


On October 10th, 2018, the American Society for Parenteral and Enteral Nutrition (ASPEN), an organization which drives the science and practice of clinical nutrition, and Baxter International Inc., a global leader in clinical nutrition, launched an educational video series on the appropriate use of parenteral nutrition (PN), as part of the organizations’ “SmartPN” collaboration to help reduce clinical malnutrition.
On October 25th, 2018, U.S. Food and Drug Administration (FDA) has cleared Abbott’s next-generation Influenza A and B2 and Strep A2 molecular assays for point-of-care testing. These new assays enable the three time fastest molecular influenza. Both the assays have been granted a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver which are currently available on the ID NOW platform (formerly known as “Alere I”).

Target Audience:
Oncology Nutrition Providers, Manufacturers and Vendors of Enteral Feeding Formulas, Research Associations Related to Enteral Nutrition and Oncology, Hospitals, Nursing Homes, and LTC Facilities, Various Research and Consulting Firms, Government Regulatory Bodies, Hospitals and Clinics and Others

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Oncology nutrition market on the basis of product [] , application [], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Oncology nutrition market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Oncology nutrition industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Vendors which are also part of the research are Hormel Foods (United States), Mead Johnson Nutrition Company (United States), Meiji Holdings Co. Ltd. (Japan), Nestle S.A. (Switzerland) and Victus (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Oncology nutrition market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Demography
  • Infants
  • Adults
  • Children
  • Others

By Cancer Type
  • Blood
  • Liver
  • Pancreatic
  • Breast
  • Lung
  • Head & Neck
  • Esophageal
  • Stomach & Gastrointestinal

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Cancer
      • 3.2.2. Rising Demand for the Nutritional Food
    • 3.3. Market Challenges
      • 3.3.1. Complications Related to Tube Feeding
      • 3.3.2. Lack of Government Assistance in Generating Reimbursements
    • 3.4. Market Trends
      • 3.4.1. Growing Instances of Extreme Weight Loss in Cancer Patients
      • 3.4.2. Increasing Demand in Homecare Sector
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Oncology nutrition, by Demography, Cancer Type and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Oncology nutrition (Value)
      • 5.2.1. Global Oncology nutrition by: Demography (Value)
        • 5.2.1.1. Infants
        • 5.2.1.2. Adults
        • 5.2.1.3. Children
        • 5.2.1.4. Others
      • 5.2.2. Global Oncology nutrition by: Cancer Type (Value)
        • 5.2.2.1. Blood
        • 5.2.2.2. Liver
        • 5.2.2.3. Pancreatic
        • 5.2.2.4. Breast
        • 5.2.2.5. Lung
        • 5.2.2.6. Head & Neck
        • 5.2.2.7. Esophageal
        • 5.2.2.8. Stomach & Gastrointestinal
      • 5.2.3. Global Oncology nutrition Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Oncology nutrition: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Aceto (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Baxter International (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BioSig Technologies (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Danone (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. FMC Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fresenius Kabi AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Global Health Products (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Hansen Medical (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Oncology nutrition Sale, by Demography, Cancer Type and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Oncology nutrition (Value)
      • 7.2.1. Global Oncology nutrition by: Demography (Value)
        • 7.2.1.1. Infants
        • 7.2.1.2. Adults
        • 7.2.1.3. Children
        • 7.2.1.4. Others
      • 7.2.2. Global Oncology nutrition by: Cancer Type (Value)
        • 7.2.2.1. Blood
        • 7.2.2.2. Liver
        • 7.2.2.3. Pancreatic
        • 7.2.2.4. Breast
        • 7.2.2.5. Lung
        • 7.2.2.6. Head & Neck
        • 7.2.2.7. Esophageal
        • 7.2.2.8. Stomach & Gastrointestinal
      • 7.2.3. Global Oncology nutrition Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Oncology nutrition: by Demography(USD Billion)
  • Table 2. Oncology nutrition Infants , by Region USD Billion (2013-2018)
  • Table 3. Oncology nutrition Adults , by Region USD Billion (2013-2018)
  • Table 4. Oncology nutrition Children , by Region USD Billion (2013-2018)
  • Table 5. Oncology nutrition Others , by Region USD Billion (2013-2018)
  • Table 6. Oncology nutrition: by Cancer Type(USD Billion)
  • Table 7. Oncology nutrition Blood , by Region USD Billion (2013-2018)
  • Table 8. Oncology nutrition Liver , by Region USD Billion (2013-2018)
  • Table 9. Oncology nutrition Pancreatic , by Region USD Billion (2013-2018)
  • Table 10. Oncology nutrition Breast , by Region USD Billion (2013-2018)
  • Table 11. Oncology nutrition Lung , by Region USD Billion (2013-2018)
  • Table 12. Oncology nutrition Head & Neck , by Region USD Billion (2013-2018)
  • Table 13. Oncology nutrition Esophageal , by Region USD Billion (2013-2018)
  • Table 14. Oncology nutrition Stomach & Gastrointestinal , by Region USD Billion (2013-2018)
  • Table 15. South America Oncology nutrition, by Country USD Billion (2013-2018)
  • Table 16. South America Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 17. South America Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 18. Brazil Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 19. Brazil Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 20. Argentina Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 21. Argentina Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 22. Rest of South America Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 23. Rest of South America Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 24. Asia Pacific Oncology nutrition, by Country USD Billion (2013-2018)
  • Table 25. Asia Pacific Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 26. Asia Pacific Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 27. China Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 28. China Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 29. Japan Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 30. Japan Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 31. India Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 32. India Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 33. South Korea Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 34. South Korea Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 35. Taiwan Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 36. Taiwan Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 37. Australia Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 38. Australia Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 39. Rest of Asia-Pacific Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 40. Rest of Asia-Pacific Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 41. Europe Oncology nutrition, by Country USD Billion (2013-2018)
  • Table 42. Europe Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 43. Europe Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 44. Germany Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 45. Germany Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 46. France Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 47. France Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 48. Italy Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 49. Italy Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 50. United Kingdom Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 51. United Kingdom Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 52. Netherlands Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 53. Netherlands Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 54. Rest of Europe Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 55. Rest of Europe Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 56. MEA Oncology nutrition, by Country USD Billion (2013-2018)
  • Table 57. MEA Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 58. MEA Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 59. Middle East Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 60. Middle East Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 61. Africa Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 62. Africa Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 63. North America Oncology nutrition, by Country USD Billion (2013-2018)
  • Table 64. North America Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 65. North America Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 66. United States Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 67. United States Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 68. Canada Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 69. Canada Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 70. Mexico Oncology nutrition, by Demography USD Billion (2013-2018)
  • Table 71. Mexico Oncology nutrition, by Cancer Type USD Billion (2013-2018)
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Oncology nutrition: by Demography(USD Billion)
  • Table 83. Oncology nutrition Infants , by Region USD Billion (2019-2024)
  • Table 84. Oncology nutrition Adults , by Region USD Billion (2019-2024)
  • Table 85. Oncology nutrition Children , by Region USD Billion (2019-2024)
  • Table 86. Oncology nutrition Others , by Region USD Billion (2019-2024)
  • Table 87. Oncology nutrition: by Cancer Type(USD Billion)
  • Table 88. Oncology nutrition Blood , by Region USD Billion (2019-2024)
  • Table 89. Oncology nutrition Liver , by Region USD Billion (2019-2024)
  • Table 90. Oncology nutrition Pancreatic , by Region USD Billion (2019-2024)
  • Table 91. Oncology nutrition Breast , by Region USD Billion (2019-2024)
  • Table 92. Oncology nutrition Lung , by Region USD Billion (2019-2024)
  • Table 93. Oncology nutrition Head & Neck , by Region USD Billion (2019-2024)
  • Table 94. Oncology nutrition Esophageal , by Region USD Billion (2019-2024)
  • Table 95. Oncology nutrition Stomach & Gastrointestinal , by Region USD Billion (2019-2024)
  • Table 96. South America Oncology nutrition, by Country USD Billion (2019-2024)
  • Table 97. South America Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 98. South America Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 99. Brazil Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 100. Brazil Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 101. Argentina Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 102. Argentina Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 103. Rest of South America Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 104. Rest of South America Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 105. Asia Pacific Oncology nutrition, by Country USD Billion (2019-2024)
  • Table 106. Asia Pacific Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 107. Asia Pacific Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 108. China Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 109. China Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 110. Japan Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 111. Japan Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 112. India Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 113. India Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 114. South Korea Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 115. South Korea Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 116. Taiwan Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 117. Taiwan Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 118. Australia Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 119. Australia Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 120. Rest of Asia-Pacific Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 121. Rest of Asia-Pacific Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 122. Europe Oncology nutrition, by Country USD Billion (2019-2024)
  • Table 123. Europe Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 124. Europe Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 125. Germany Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 126. Germany Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 127. France Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 128. France Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 129. Italy Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 130. Italy Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 131. United Kingdom Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 132. United Kingdom Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 133. Netherlands Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 134. Netherlands Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 135. Rest of Europe Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 136. Rest of Europe Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 137. MEA Oncology nutrition, by Country USD Billion (2019-2024)
  • Table 138. MEA Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 139. MEA Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 140. Middle East Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 141. Middle East Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 142. Africa Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 143. Africa Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 144. North America Oncology nutrition, by Country USD Billion (2019-2024)
  • Table 145. North America Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 146. North America Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 147. United States Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 148. United States Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 149. Canada Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 150. Canada Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 151. Mexico Oncology nutrition, by Demography USD Billion (2019-2024)
  • Table 152. Mexico Oncology nutrition, by Cancer Type USD Billion (2019-2024)
  • Table 153. Research Programs/Design for This Report
  • Table 154. Key Data Information from Secondary Sources
  • Table 155. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Oncology nutrition: by Demography USD Billion (2013-2018)
  • Figure 5. Global Oncology nutrition: by Cancer Type USD Billion (2013-2018)
  • Figure 6. South America Oncology nutrition Share (%), by Country
  • Figure 7. Asia Pacific Oncology nutrition Share (%), by Country
  • Figure 8. Europe Oncology nutrition Share (%), by Country
  • Figure 9. MEA Oncology nutrition Share (%), by Country
  • Figure 10. North America Oncology nutrition Share (%), by Country
  • Figure 11. Global Oncology nutrition share by Players 2018 (%)
  • Figure 12. Global Oncology nutrition share by Players (Top 3) 2018(%)
  • Figure 13. Global Oncology nutrition share by Players (Top 5) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 16. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 17. Aceto (United States) Revenue, Net Income and Gross profit
  • Figure 18. Aceto (United States) Revenue: by Geography 2018
  • Figure 19. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 20. B. Braun Melsungen AG (Germany) Revenue: by Geography 2018
  • Figure 21. Baxter International (United States) Revenue, Net Income and Gross profit
  • Figure 22. Baxter International (United States) Revenue: by Geography 2018
  • Figure 23. BioSig Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 24. BioSig Technologies (United States) Revenue: by Geography 2018
  • Figure 25. Danone (France) Revenue, Net Income and Gross profit
  • Figure 26. Danone (France) Revenue: by Geography 2018
  • Figure 27. FMC Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. FMC Corporation (United States) Revenue: by Geography 2018
  • Figure 29. Fresenius Kabi AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Fresenius Kabi AG (Germany) Revenue: by Geography 2018
  • Figure 31. Global Health Products (United States) Revenue, Net Income and Gross profit
  • Figure 32. Global Health Products (United States) Revenue: by Geography 2018
  • Figure 33. Hansen Medical (United States) Revenue, Net Income and Gross profit
  • Figure 34. Hansen Medical (United States) Revenue: by Geography 2018
  • Figure 35. Global Oncology nutrition: by Demography USD Billion (2013-2018)
  • Figure 36. Global Oncology nutrition: by Cancer Type USD Billion (2013-2018)
  • Figure 37. South America Oncology nutrition Share (%), by Country
  • Figure 38. Asia Pacific Oncology nutrition Share (%), by Country
  • Figure 39. Europe Oncology nutrition Share (%), by Country
  • Figure 40. MEA Oncology nutrition Share (%), by Country
  • Figure 41. North America Oncology nutrition Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • Aceto (United States)
  • B. Braun Melsungen AG (Germany)
  • Baxter International (United States)
  • BioSig Technologies (United States)
  • Danone (France)
  • FMC Corporation (United States)
  • Fresenius Kabi AG (Germany)
  • Global Health Products (United States)
  • Hansen Medical (United States)
Additional players considered in the study are as follows:
Hormel Foods (United States) , Mead Johnson Nutrition Company (United States) , Meiji Holdings Co. Ltd. (Japan) , Nestle S.A. (Switzerland) , Victus (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation